Addiction

Adial Pharmaceuticals Announces Closing of $5 Million Private Placement Priced at a Premium to Market

Thursday, August 5, 2021 - 3:12pm

In combination with the private placement previously announced on June 3, 2021, this transaction marks the completion of a set of financings totaling $7.1 million.

Key Points: 
  • In combination with the private placement previously announced on June 3, 2021, this transaction marks the completion of a set of financings totaling $7.1 million.
  • William Stilley, Adials Chief Executive Officer, commented, We are pleased to close this last piece of our $7.1 million in private placements, and we appreciate the support of the participating investors.
  • Additionally, it is expected to allow us to achieve key milestones for our pre-clinical adenosine program for non-opiate pain relief.
  • Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions.

Better Therapeutics, Inc. to Present at the Canaccord Genuity’s 41st Annual Growth Conference

Wednesday, August 4, 2021 - 1:00pm

Better Therapeutics, Inc. (Better Therapeutics), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced its team is participating in the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021.

Key Points: 
  • Better Therapeutics, Inc. (Better Therapeutics), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced its team is participating in the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021.
  • The cognitive behavioral therapy delivered by Better Therapeutics PDTs enables changes in neural pathways of the brain so lasting changes in behavior become possible.
  • Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs.
  • Better Therapeutics clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.

Workit Health Expands Digital Addiction and Mental Health Care to Oregon

Thursday, July 29, 2021 - 6:00pm

Through Workit's mobile and web apps, people struggling with addiction in Oregon will be able to receive insurance-covered clinical and counseling services.

Key Points: 
  • Through Workit's mobile and web apps, people struggling with addiction in Oregon will be able to receive insurance-covered clinical and counseling services.
  • Workit Health was founded in 2015 by Robin McIntosh and Lisa McLaughlin, two women in long-term recovery from addiction themselves.
  • Workit Health is an addiction healthcare B-corporation offering online, on-demand evidence-based addiction treatment including telehealth medication for opioid use disorder.
  • Workit Health partners with healthcare organizations to deliver an innovative digital health solution that blends the best of human-centered design, technology, and science.

Katherine Bonincontri is recognized by Continental Who's Who

Wednesday, July 28, 2021 - 6:57pm

CROFTON, Md., July 28, 2021 /PRNewswire/ --Katherine Bonincontri is being recognized by Continental Who's Who as a Trusted Executive in the field of Behavioral and Mental Health Services and for her outstanding contributions as President & Executive Director at Robert A. Pascal Youth & Family Services.

Key Points: 
  • CROFTON, Md., July 28, 2021 /PRNewswire/ --Katherine Bonincontri is being recognized by Continental Who's Who as a Trusted Executive in the field of Behavioral and Mental Health Services and for her outstanding contributions as President & Executive Director at Robert A. Pascal Youth & Family Services.
  • Throughout her distinguished career, Mrs. Katherine Bonincontri has made a great impact in her community, fueled by her passion for caring for people and their psychological wellbeing.
  • In her current capacity, Mrs. Bonincontri provides innovative treatments to individuals with behavioral health and substance abuse disorders.
  • Mrs. Bonincontri dedicates this honorable recognition with special thanks to my husband of seven years, Phillip Bonincontri.

Braxia Scientific CEO, Chief Medical Officer Awarded $918,000 by Canadian Government to Study Benefits of Integrating Ketamine with Cognitive Behavioural Therapy to Reduce Suicidality

Wednesday, July 28, 2021 - 12:31pm

The funding will be used to evaluate the effectiveness of intravenous ketamine, in combination with internet-based cognitive behavioural therapy (iCBT), to rapidly reduce suicidality in persons with depression, when compared to iCBT alone.

Key Points: 
  • The funding will be used to evaluate the effectiveness of intravenous ketamine, in combination with internet-based cognitive behavioural therapy (iCBT), to rapidly reduce suicidality in persons with depression, when compared to iCBT alone.
  • It is separately reported in the biomedical literature that cognitive behavioural therapy may also reduce suicidality, but requires several weeks to months before reductions in suicidality are significant.
  • "Integrating ketamine with CBT provides an opportunity to rapidly reduce suicidality and sustain the effect over the long term.
  • Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders.

Break Free from Marijuana Addiction with New 30-Day Online Program

Monday, July 26, 2021 - 1:38pm

An innovative way to overcome marijuana addiction in the comfort of a customer's own home.

Key Points: 
  • An innovative way to overcome marijuana addiction in the comfort of a customer's own home.
  • The CAARE Program is a 30-day step-by-step program that has the tools needed to overcome marijuana addiction.
  • With the CAARE Program, users can follow a proven plan to break free of addiction, intentionally create the life they want, and live every day forward on their own terms.
  • To find out more about the CAARE Program or the highly-rated The Secret Addiction book, please visit www.secretaddiction.org .

Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Friday, July 23, 2021 - 1:45pm

A leader in addiction and substance abuse treatments, ACT Medical hosted more than 35,000 patient visits in the past 12 months.

Key Points: 
  • A leader in addiction and substance abuse treatments, ACT Medical hosted more than 35,000 patient visits in the past 12 months.
  • Share purchase agreement to acquire BlockMD LTD. (BlockMD), which operates a leading telemedicine platform used by addiction patients to access doctors and order prescriptions in Alberta, for $1,475,000 (the BlockMD Purchase Price).
  • Through these acquisitions, we expect Levitee will become the largest non-government provider of addiction treatment services in Alberta.
  • Levitee also aims to include psilocybin- and ibogaine-based treatment options as soon as it is legally possible to do so.

Health Canada Launches National Call for Proposals for the Substance Use and Addictions Program

Thursday, July 22, 2021 - 6:53pm

"Through Canada's Substance Use and Addictions Program and this call for proposals we are working with community-based organizations to provide much-needed support to those that need it, reducing harms and reducing deaths.

Key Points: 
  • "Through Canada's Substance Use and Addictions Program and this call for proposals we are working with community-based organizations to provide much-needed support to those that need it, reducing harms and reducing deaths.
  • Since SUAP was established in 2016, there have been 2 national calls for proposals (2017, 2019).
  • These national calls for proposals, along with other targeted investments, have resulted in over 200 projects across Canada worth over $360 million.
  • Tragically, the latest national data indicates that 2020 was the worst year for opioid-related deaths since the Public Health Agency of Canada (PHAC) began monitoring the crisis in 2016.

Prevent Opioid Abuse Calls on Congress to Pass the Opioid Patients’ Right to Know Act

Thursday, July 22, 2021 - 4:00pm

Pointing to the record number of opioid overdoses in the wake of the COVID-19 pandemic, Prevent Opioid Abuse today called on Congress to help put the brakes on further spikes in dependence and addiction throughout the nation by moving expeditiously to pass the Opioid Patients Right to Know Act (H1185).

Key Points: 
  • Pointing to the record number of opioid overdoses in the wake of the COVID-19 pandemic, Prevent Opioid Abuse today called on Congress to help put the brakes on further spikes in dependence and addiction throughout the nation by moving expeditiously to pass the Opioid Patients Right to Know Act (H1185).
  • The Opioid Patients Right to Know Act would create a grant program to incentivize states to require prescribers to discuss the addictive qualities of the drugs with patients and inform them of alternative treatment options before prescribing them for acute pain.
  • The Opioid Patients Right to Know Act provides the incentives needed to persuade every state in the nation to adopt this proven prevention measure.
  • The Opioid Patients Right to Know Act is sponsored by U.S. Representative David Trone (D-MD), along with Reps.

ZoomCare Expands Mental Health Offering With Launch of Virtual Therapy

Tuesday, July 20, 2021 - 4:00pm

Mental Health Therapy encompasses on-demand mental health video visits, live with a licensed therapist.

Key Points: 
  • Mental Health Therapy encompasses on-demand mental health video visits, live with a licensed therapist.
  • The ZoomCare Mental Health team offers a variety of services, with in-person and virtual options, using evidence-based techniques such as Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT).
  • Patients can utilize Mental Health Therapy in conjunction with other ZoomCare services, such as its Mental Health Meds & More service which also has the capacity to prescribe mental health medications from trained mental health clinicians, and its online communication tool ChatCare.
  • "We're pleased to be able to offer Mental Health Therapy, our evidence-based virtual mental health counseling offering, to those in our Oregon communities who are seeking mental health support," said Dr. Erik Vanderlip, MD, MPH, Chief Medical Officer of ZoomCare and board-certified family physician and psychiatrist.